Journal of Clinical Pathology 2008;61:25-30
DEMYSTIFIED
Molecular pathology of familial gastric cancer, with an emphasis on hereditary diffuse gastric cancer
1 Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal
2 Medical Faculty of the University of Porto, Porto, Portugal
3 Department of Pathology, Hospital S. João, Porto, Portugal
Dr Fátima Carneiro, Rua Dr Roberto frias s/n, 4200-465 Porto, Portugal; fcarneiro{at}ipatimup.pt
Gastric cancer is one of the major causes of cancer-related death worldwide. Familial clustering is observed in about 10% of cases; 1–3% of cases are hereditary. In the latter group, a syndrome which has been well characterised is hereditary diffuse gastric cancer; this is specifically associated with CDH1 (E-cadherin) germline mutations in about 30% of families. In this article, the state of the art of familial gastric cancer regarding the clinical, molecular and pathology features is reviewed, as well as the practical aspects for a correct diagnosis and clinical management.
This article has been cited by other articles:
-
Simoes-Correia, J., Figueiredo, J., Oliveira, C., van Hengel, J., Seruca, R., van Roy, F., Suriano, G.
(2008). Endoplasmic reticulum quality control: a new mechanism of E-cadherin regulation and its implication in cancer. Hum Mol Genet
17: 3566-3576
[Abstract] [Full Text] -
Khushalani, N. I.
(2008). Cancer of the Esophagus and Stomach. Mayo Clin Proc.
83: 712-722
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
